This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Ilaria Stanghellini: Innovator in Stem Cell Research
Introduction
Ilaria Stanghellini is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of stem cell research, particularly in understanding the mechanisms of embryonic stem cell differentiation. Her work has implications for regenerative medicine and developmental biology.
Latest Patents
Ilaria holds a patent titled "Methods for modulating embryonic stem cell differentiation." This patent describes Zscan4, a gene that exhibits specific expression during the 2-cell embryonic stage and in embryonic stem cells. The patent details the identification of nine co-expressed genes associated with Zscan4. It also discusses how inhibiting Zscan4 expression can prevent the transition from the 2-cell to the 4-cell embryonic stage, as well as impede blastocyst implantation, expansion, and outgrowth. The patent provides methods for inhibiting stem cell differentiation, promoting blastocyst outgrowth of embryonic stem cells, and identifying a subpopulation of stem cells that express Zscan4. Additionally, it identifies Trim43 as a gene with morula-specific expression and includes isolated expression vectors linked to Zscan4 and Trim43 promoters.
Career Highlights
Ilaria Stanghellini works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her research has garnered attention for its innovative approach to stem cell biology and its potential applications in medical science.
Collaborations
Ilaria collaborates with notable colleagues, including Manuela Monti and Minoru S H Ko. Their combined expertise enhances the research efforts in the field of embryonic stem cell differentiation.
Conclusion
Ilaria Stanghellini's contributions to stem cell research through her innovative patent work exemplify the importance of scientific inquiry in understanding complex biological processes. Her research continues to pave the way for advancements in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile